These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22206597)

  • 21. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
    Valea I; Tinto H; Drabo MK; Huybregts L; Sorgho H; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Kolsteren P; D'Alessandro U;
    Malar J; 2012 Mar; 11():71. PubMed ID: 22433778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
    Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
    Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Prevalence of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine in Parts of Ghana: A Threat to ITPTp-SP?
    Afutu LL; Boampong JN; Quashie NB
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33404643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
    Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
    Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015.
    Oppong FB; Gyaase S; Zandoh C; Nettey OEA; Amenga-Etego S; Anane EA; Adda R; Dosoo DK; Owusu-Agyei S; Asante KP
    BMJ Open; 2019 Jun; 9(6):e027946. PubMed ID: 31230017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
    Falade CO; Yusuf BO; Fadero FF; Mokuolu OA; Hamer DH; Salako LA
    Malar J; 2007 Jul; 6():88. PubMed ID: 17617910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
    Challis K; Osman NB; Cotiro M; Nordahl G; Dgedge M; Bergström S
    Trop Med Int Health; 2004 Oct; 9(10):1066-73. PubMed ID: 15482398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
    Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
    Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
    PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
    Amoako BK; Anto F
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana.
    Dosoo DK; Malm K; Oppong FB; Gyasi R; Oduro A; Williams J; Atibilla D; Peprah NY; Twumasi M; Owusu-Agyei S; Greenwood B; Chandramohan D; Asante KP
    BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34417272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
    Fokam EB; Ngimuh L; Anchang-Kimbi JK; Wanji S
    Malar J; 2016 Mar; 15():172. PubMed ID: 26987387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The demand for intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta Region of Ghana.
    Asem L; Abdulia AG; Assuming PO; Abeka-Nkrumah G
    PLoS One; 2024; 19(9):e0308321. PubMed ID: 39236029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.